Leukemia Research
Volume 33, Issue 11 , Pages 1567-1569 , November 2009

Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery

  • Hana Klamová

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • ,
  • Markéta Marková

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • ,
  • Jana Moravcová

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • ,
  • Magda Šišková

      Affiliations

    • 1st Medical Department – Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic
    • ,
  • Petr Cetkovský

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • ,
  • Kateřina Machová Poláková

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 221 977 181; fax: +420 221 977 397.

Received 22 January 2009 ,Revised 14 May 2009 ,Accepted 16 May 2009.

References 

  1. Lichtman M, Liesveld J. Acute myelogeneous leukemia. In:  Beutler E,  Lichtman M,  Coller B, et al. editor. Williams hematology. 6th ed.. New York, NY: McGraw-Hill; 2001;p. 1047–1084
  2. Pye SM, Cortes JS, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. The effects of imatinib on pregnancy outcome. Blood. 2008;111:5505–5508
  3. Klaasen R, de Jong P, Wijermans PW. Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy. The Netherland Journal of Medicine. 2007;65:147–149
  4. Yan J, Hales BF. Activator protein-1 (AP-1) DNA binding activity is induced by hydroxyurea in organogenesis stage mouse embryos. Toxicological Sciences. 2005;85:1013–1023
  5. Baer MR, Ozer H, Foon KA. Interferon-α therapy during pregnancy in chronic myelogeneous leukaemia and hairy cell leukaemia. British Journal of Haematology. 1992;81:167–169
  6. Machova Polakova K, Zmekova V, Rulcova J, Klamova H, Zemanova Z, Moravcova J. BCR-ABL mutations in chronic myeloid leukemia—not only detection. Leukemia and Lymphoma. 2008;49:1620–1622
  7. Rulcova J, Zmekova V, Zemanova Z, Klamova H, Moravcova J. The effect of total-ABL, GUS and B2M control gene in BCR-ABL monitoring by real-time RT-PCR. Leukemia Research. 2007;31:483–491
  8. Machova Polakova K, Lopotova T, Klamova H, Moravcova J. High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain. Leukemia Research. 2008;32:1236–1243

PII: S0145-2126(09)00262-8

doi: 10.1016/j.leukres.2009.05.012

Leukemia Research
Volume 33, Issue 11 , Pages 1567-1569 , November 2009

Article Tools